Inducing immunogenic cell death in immuno-oncological therapies

Dongdong Ti, Xin Yan, Jianshu Wei, Zhiqiang Wu, Yao Wang, Weidong Han

2022, 34(1): 1-10. doi: 10.21147/j.issn.1000-9604.2022.01.01

Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma

Shichao Guo, Guangchao Wang, Zitong Zhao, Dan Li, Yongmei Song, Qimin Zhan

2022, 34(1): 11-27. doi: 10.21147/j.issn.1000-9604.2022.01.02

Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update

Jun Lu, Tianqing Chu, Hongyu Liu, Minjuan Hu, Yuqing Lou, Yanwei Zhang, Zhiqiang Gao, Wei Zhang, Xueyan Zhang, Huimin Wang, Hua Zhong, Baohui Han

2022, 34(1): 28-39. doi: 10.21147/j.issn.1000-9604.2022.01.03

Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer

Yanqi Huang, Lan He, Zhenhui Li, Xin Chen, Chu Han, Ke Zhao, Yuan Zhang, Jinrong Qu, Yun Mao, Changhong Liang, Zaiyi Liu

2022, 34(1): 40-52. doi: 10.21147/j.issn.1000-9604.2022.01.04

A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma

Zhitao Ying, Ting He, Shanzhao Jin, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Weiping Liu, Lijuan Deng, Yanping Ding, Xuelian Hu, Bing Bu, Xin’an Lu, Yuqin Song, Jun Zhu

2022, 34(1): 53-62. doi: 10.21147/j.issn.1000-9604.2022.01.05

Open surgery in the era of minimally invasive surgery

Zichen Zhao, Jin Gu

2022, 34(1): 63-65. doi: 10.21147/j.issn.1000-9604.2022.01.06

Corrigendum to Tumor-associated macrophages regulate gastric cancer cell invasion and metastasis through TGFβ2/NF-κB/Kindlin-2 axis

2022, 34(1): 66-66. doi: 10.21147/j.issn.1000-9604.2022.01.07